The HLA-G*0105N null allele induces cell surface expression of HLA-E molecule and promotes CD94/NKG2A-mediated recognition in JAR choriocarcinoma cell line

被引:24
作者
Sala, FG [1 ]
Del Moral, PM [1 ]
Pizzato, N [1 ]
Legrand-Abravanel, F [1 ]
Le Bouteiller, P [1 ]
Lenfant, F [1 ]
机构
[1] Hop Purpan, Ctr Physiopathol Toulouse Purpan, INSERM, U563, F-31024 Toulouse 3, France
关键词
HLA-G; polymorphism; HLA-E; pregnancy; natural killer cell;
D O I
10.1007/s00251-004-0733-7
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
HLA-G is a non-classical HLA class Ib molecule primarily expressed in trophoblast cells, and is thought to play a key role in the induction of maternofetal tolerance during pregnancy. In addition, the HLA-G gene provides a suitable leader sequence peptide capable of binding to HLA-E. However, the existence of placentas homozygous for the HLA-G*0105N null allele suggests that HLA-G1 might not be essential for fetal survival. To investigate whether expression of the HLA-G* 0105N allele supports HLA-E cell surface expression, we transfected the HLA-G* 0105N gene into JAR trophoblast cells. Flow cytometry analysis showed that HLA-G* 0105N-transfected cells express surface HLA-E to a similar extent as the unmutated HLA-G gene, whereas HLA-G1 cell surface expression was undetectable. Using the NKL cell line in a standard Cr-51 release assay, the HLA-E molecules were found to inhibit natural killer lysis, through a mechanism partially dependent on CD94/NKG2A-mediated recognition.
引用
收藏
页码:617 / 624
页数:8
相关论文
共 35 条
[1]  
Agrawal S, 1999, J IMMUNOL, V162, P1223
[2]  
AIYAR A, 1993, BIOTECHNIQUES, V14, P366
[3]   The short forms of HLA-G are unlikely to play a role in pregnancy because they are not expressed at the cell surface [J].
Bainbridge, DRJ ;
Ellis, SA ;
Sargent, IL .
JOURNAL OF REPRODUCTIVE IMMUNOLOGY, 2000, 47 (01) :1-16
[4]   HLA-E IS THE ONLY CLASS-I GENE THAT ESCAPES CPG METHYLATION AND IS TRANSCRIPTIONALLY ACTIVE IN THE TROPHOBLAST-DERIVED HUMAN CELL-LINE JAR [J].
BOUCRAUT, J ;
GUILLAUDEUX, T ;
ALIZADEH, M ;
BORETTO, J ;
CHIMINI, G ;
MALECAZE, F ;
SEMANA, G ;
FAUCHET, R ;
PONTAROTTI, P ;
LEBOUTEILLER, P .
IMMUNOGENETICS, 1993, 38 (02) :117-130
[5]   The inhibitory receptor LIR-1 uses a common binding interaction to recognize class I MHC molecules and the viral homolog UL18 [J].
Chapman, TL ;
Heikema, AP ;
Bjorkman, PJ .
IMMUNITY, 1999, 11 (05) :603-613
[6]   A common inhibitory receptor for major histocompatibility complex class I molecules on human lymphoid and myelomonocytic cells [J].
Colonna, M ;
Navarro, F ;
Bellon, T ;
Llano, M ;
Garcia, P ;
Samaridis, J ;
Angman, L ;
Cella, M ;
LopezBotet, M .
JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 186 (11) :1809-1818
[7]   Nonclassical HLA-G molecules are classical peptide presenters [J].
Diehl, M ;
Munz, C ;
Keilholz, W ;
Stevanovic, S ;
Holmes, N ;
Loke, YW ;
Rammensee, HG .
CURRENT BIOLOGY, 1996, 6 (03) :305-314
[8]   Soluble HLA-G1 triggers CD95/CD95 ligand-mediated apoptosis in activated CD8+ cells by interacting with CD8 [J].
Fournel, S ;
Aguerre-Girr, M ;
Huc, X ;
Lenfant, F ;
Alam, A ;
Toubert, A ;
Bensussan, A ;
Le Bouteiller, P .
JOURNAL OF IMMUNOLOGY, 2000, 164 (12) :6100-6104
[9]  
FUJII T, 1994, J IMMUNOL, V153, P5516
[10]   Classical and nonclassical class I major histocompatibility complex molecules exhibit subtle conformational differences that affect binding to CD8αα [J].
Gao, GF ;
Willcox, BE ;
Wyer, JR ;
Boulter, JM ;
O'Callaghan, CA ;
Maenaka, K ;
Stuart, DI ;
Jones, EY ;
Van Der Merwe, PA ;
Bell, JI ;
Jakobsen, BK .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (20) :15232-15238